Neo-Bionica appoints internationally recognised CEO and Chair
Posted 1 September 2021 Neo-Bionica, a joint venture between Bionics Institute and The University of Melbourne has announced the appointment of two extremely well credentialled individuals. Dr Ludovic Labat has been appointed as CEO while BioMelbourne Network’s own Lusia Guthrie has…
Partnership to develop new drugs for childhood solid tumours
Posted 29 August 2021 BioMelbourne Network member Oncology One has announced a new partnership with Children’s Cancer Institute to develop new drugs for the treatment of childhood solid tumours. The partnership is focused on the development of novel…
Industry survey: Impact of the pandemic on freight and logistics for Victorian Healthtech
Industry survey in partnership between Global Victoria and BioMelbourne Network An opportunity for you to engage and take a short survey to inform our work on a critical issue to the Healthtech Industry Keep informed about the Issues…
BioForum: Future Direction for mRNA Technology meeting recording
Posted 23 August 2021 Thank you to all those who attended our BioForum: Future Direction for mRNA Technology on Tuesday 10 August 2021, sponsored by the State Government of Victoria, in collaboration with mRNA Victoria. For those who…
ANDHealth Receives $19.75M From Medical Research Future Fund
Posted 20 August 2021 ANDHealth, Australia’s leading digital health commercialisation organisation, has today announced it has been successful in securing $19.75M in funding received from the Australian Federal Government under the Medical Research Future Fund (MRFF) Early Stage…
BioAgilytix to purchase Australia-based 360biolabs
Posted 17 August 2021 BioMelbourne Network member, BioAgilytix, a leading global contract research laboratory focused on supporting its pharmaceutical and biotech partners in all stages of large molecule drug development, announced today that it signed a definitive agreement…
Imagion Biosystems enters agreement for treating breast cancer
Posted 16 August 2021 BioMelbourne member Imagion Biosystems Limited, a company dedicated to improving healthcare through the earlier detection of cancer, is pleased to announce it has entered into a Joint Development Agreement with Global Cancer Technology (GCT),…
An update on the impact of COVID-19 on Researchers
Posted 10 August 2021 The presence of COVID-19 in our community has disrupted the lives of every single Australian. As the national voice of the health and medical research sector, Research Australia has committed to understanding the specific…
4DMedical signs commercial contract with pharmaceutical company
Posted 9 August 2021 Respiratory imaging disruptor and BioMelbourne Network member 4DMedical today announced the signing of a commercial contract with Novartis. Under the terms of the agreement, XV Ventilation Reports will be provided to Novartis on a…
BioCurate and Monash accelerate research into treatments for breast cancer
Posted: 2 August 2021 The first award under BioCurate’s new “Proof of Concept” fund has been granted to the Monash Biomedicine Discovery Institute (BDI). This award will support the key research needed to determine the effectiveness of targeting…
Immutep completes second tranche of institutional placement
Posted: 2 August 2021 BioMelbourne Network member Immutep has completed the second tranche of its institutional placement, details of which were announced to the market on 21 June 2021. The second tranche of the Placement comprises the…
CTxONE Launches New Name, New Brand > Oncology One
Posted: 27 July 2021 Australian biotech company and BioMelbourne member, CTxONE, has announced it has re-branded to ‘Oncology One’ – a move that will support its goal to raise and deploy meaningful capital to progress small molecule cancer…
